Latest Breaking News On - Ruijun chen - Page 1 : comparemela.com

Jul 26, 2021 MONDAY, July 26, 2021 (HealthDay News) For patients with hypertension initiating treatment, effectiveness is comparable for angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), but ARBs have a better safety profile, according to a study published online July 26 in Hypertension. RuiJun Chen, M.D., from the Columbia University Irving Medical Center in New York City, and colleagues compared the real-world effectiveness and safety of ACE inhibitors versus ARBs in first-line treatment of hypertension. All patients with hypertension initiating monotherapy with an ACE inhibitor or ARB between 1996 and 2018 from eight databases across the United States, Germany, and South Korea were included.

New yorkUnited statesSouth koreaRuijun chenColumbia university irving medical centerHealthday newsJun chenNew york cityபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்தெற்கு கொரியாகொலம்பியா பல்கலைக்கழகம் இவிஂக் மருத்துவ மையம்ஜூன் சென்புதியது யார்க் நகரம்